Product Description
Our vision to excel and establish a strong foothold in the market has assisted us to evolve as a prominent organization engaged in offering Cytarabine Medicine. This medicine works by inhibiting the growth and spread of cancer cells in the body. We source this medicine from the certified vendors of the market with the help of our agents. Cytarabine Medicine is used alone or in combination with other medications to treat a certain type of cancer of the colon or rectum. We offer this medicine at affordable prices to clients.
Features:
- Extended shelf life
- Effective anti cancer drug
- Accurate composition
Further Details:
Cytarabine is used with or without radiation therapy or other medications to treat a certain type of cancer of the head and neck.
Targeted Antileukemic ActionCytarabine Injection is a highly effective chemotherapy agent designed to combat specific types of leukemia, including AML, ALL, and CML. It disrupts the proliferation of malignant cells, making it a cornerstone in cancer treatment protocols. Its precise action leads to improved outcomes in appropriately selected patients.
Safe and Professional AdministrationThis medicine is strictly for administration by qualified healthcare professionals due to its potent effects and risk profile. It is delivered intravenously or subcutaneously, with options for dilution using compatible solutions. Proper administration and monitoring are essential to ensure patient safety and optimal therapeutic benefit.
Packaging and Storage IntegrityEach dose is packaged in a secure glass vial, maintaining the stability and purity of the solution. To preserve efficacy, store the vials below 25C and avoid exposure to light. This ensures the products ready availability and effectiveness throughout its 24-month shelf life.
FAQs of Cytarabine Medicine:
Q: How should Cytarabine Injection 100 mg/2 mL be administered?
A: Cytarabine Injection is administered either intravenously or subcutaneously by a healthcare professional. The dosage and schedule will be determined by the treating physician based on the type of leukemia and patient condition.
Q: What types of cancer is Cytarabine used to treat?
A: Cytarabine is primarily indicated for the treatment of certain leukemias, specifically acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML).
Q: When do I need to use Cytarabine and who decides on the therapy?
A: Cytarabine therapy is prescribed following a confirmed diagnosis of applicable leukemia types. Only registered medical practitioners can decide if and when its use is appropriate for you based on diagnostic findings.
Q: Where should Cytarabine be stored for optimal preservation?
A: Store Cytarabine Injection below 25C in a light-protected area. Do not freeze the vial and keep it out of reach of unauthorized individuals to maintain product integrity and safety.
Q: What is the process for preparation and compatibility for dilution?
A: If dilution is required, Cytarabine Injection is compatible with 5% dextrose and 0.9% sodium chloride solutions. Preparation and dilution should only be performed by qualified healthcare staff under sterile conditions.
Q: What are the benefits of using Cytarabine for leukemia treatment?
A: Cytarabine is highly effective in targeting and destroying abnormal leukemia cells, often resulting in improved remission rates and better disease control. Its targeted action helps limit the progression of leukemia and can significantly support recovery when used appropriately.
Q: Is Cytarabine safe for self-administration?
A: No, Cytarabine Injection should never be self-administered. It must be given by trained medical personnel to minimize risks and ensure proper handling due to its potent nature and potential side effects.